Another benefit of targeting NA with seasonal influenza vaccines is cross-protection against potential pandemic viruses, as demonstrated against avian H5N1 influenza in mice immunized with N1 from a circulating human A(H1N1) strain12. The gene discussed is XK; the disease is influenza.